UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G/A

Amendment No. 1*

  

Under the Securities Exchange Act of 1934

 

Soleno Therapeutics, Inc.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

834203200

(CUSIP Number)

 

December 31, 2019

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨Rule 13d-1(b)
xRule 13d-1(c)
¨Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

  



1

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Larry N. Feinberg

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ¨

(b) ¨

 

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY

 

EACH

 

REPORTING

 

PERSON

 

WITH:

 

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

5,700,047 *

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

5,700,047 *

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

5,700,047 *

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

12.3% **

12

TYPE OF REPORTING PERSON (See Instructions)

 

IN

         

* Includes 1,829,420 shares of common stock (“Shares”) issuable upon exercise of warrants.

** This percentage is based on a total of 46,487,474 Shares outstanding, which is the sum of 44,658,054 Shares outstanding as of November 1, 2019, as reported by the Issuer in its Quarterly Report on Form 10-Q, dated November 8, 2019 (the “Quarterly Report”), plus 1,829,420 warrants that are currently exercisable.

 

 

 

 

1

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Oracle Partners, LP

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ¨

(b) ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY

 

EACH

 

REPORTING

 

PERSON

 

WITH:

 

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

3,912,425 *

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

3,912,425 *

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,912,425 *

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

8.5% **

12

TYPE OF REPORTING PERSON (See Instructions)

 

PN

         

* Includes 1,247,375 Shares issuable upon exercise of warrants.

** This percentage is based on a total of 45,905,429 Shares outstanding, which is the sum of 44,658,054 Shares outstanding as of November 1, 2019, as reported by the Issuer in its Quarterly Report, plus 1,247,375 warrants that are currently exercisable.

 

 

 

 

 

1

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Oracle Institutional Partners, LP

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ¨

(b) ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY

 

EACH

 

REPORTING

 

PERSON

 

WITH:

 

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

516,588 *

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

516,588 *

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

516,588 *

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.2% **

12

TYPE OF REPORTING PERSON (See Instructions)

 

PN

         

* Includes 166,254 Shares issuable upon exercise of warrants.

** This percentage is based on a total of 44,824,308 Shares outstanding, which is the sum of 44,658,054 Shares outstanding as of November 1, 2019, as reported by the Issuer in its Quarterly Report, plus 166,254 warrants that are currently exercisable.

  

 

 

 

1

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Oracle Ten Fund, LP

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ¨

(b) ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY

 

EACH

 

REPORTING

 

PERSON

 

WITH:

 

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

1,271,034 *

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

1,271,034 *

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,271,034 *

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

2.8% **

12

TYPE OF REPORTING PERSON (See Instructions)

 

PN

         

* Includes 415,791 Shares issuable upon exercise of warrants.

** This percentage is based on a total of 45,073,845 Shares outstanding, which is the sum of 44,658,054 Shares outstanding as of November 1, 2019, as reported by the Issuer in its Quarterly Report, plus 415,791 warrants that are currently exercisable.

 

 

 

 

 

1

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Oracle Associates, LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ¨

(b) ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY

 

EACH

 

REPORTING

 

PERSON

 

WITH:

 

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

5,700,047 *

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

5,700,047 *

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

5,700,047 *

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)   ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

12.3% **

12

TYPE OF REPORTING PERSON (See Instructions)

 

IN

           

* Includes 1,829,420 Shares issuable upon exercise of warrants.

** This percentage is based on a total of 46,487,474 Shares outstanding, which is the sum of 44,658,054 Shares outstanding as of November 1, 2019, as reported by the Issuer in its Quarterly Report, plus 1,829,420 warrants that are currently exercisable.

 

 

 

1

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Oracle Investment Management, Inc.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ¨

(b) ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY

 

EACH

 

REPORTING

 

PERSON

 

WITH:

 

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

5,700,047 *

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

5,700,047 *

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

5,700,047 *

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

12.3% **

12

TYPE OF REPORTING PERSON (See Instructions)

 

IN

         

* Includes 1,829,420 Shares issuable upon exercise of warrants.

** This percentage is based on a total of 46,487,474 Shares outstanding, which is the sum of 44,658,054 Shares outstanding as of November 1, 2019, as reported by the Issuer in its Quarterly Report, plus 1,829,420 warrants that are currently exercisable.

 

 

 

 

This Amendment No. 1 to Schedule 13G (this “Amendment No. 1”) is being filed with respect to the Common Stock, par value $0.001 (“Common Stock”) of Soleno Therapeutics, Inc., a Delaware corporation (the “Issuer”), to amend the Schedule 13G filed on December 15, 2017 (the “Schedule 13G”), in accordance with the annual amendment requirements. This Amendment No. 1 is being filed on behalf of Oracle Partners, LP, a Delaware limited partnership (“Oracle Partners”), Oracle Ten Fund, LP, a Delaware limited partnership (“Oracle Ten Fund”), Oracle Institutional Partners, LP, a Delaware limited partnership (“Institutional Partners” and, collectively with Oracle Partners and Oracle Ten Fund, the “Oracle Partnerships”), Oracle Associates, LLC, a Delaware limited liability company and the general partner of Oracle Partners, Oracle Ten Fund and Institutional Partners (“Oracle Associates”), Oracle Investment Management, Inc., a Delaware corporation and the investment manager to the Oracle Partnerships (the “Investment Manager”), and Larry N. Feinberg, the managing member of Oracle Associates and the sole shareholder, director and president of the Investment Manager (each of the foregoing, a “Reporting Person” and collectively, the “Reporting Persons”). Capitalized terms used but not defined herein have the meaning ascribed thereto in the Schedule 13G.

 

Item 4. Ownership:

 

Item 4 of the Schedule 13G is hereby amended and restated as follows:

 

A. Larry N. Feinberg

 

(a) Amount beneficially owned: 5,700,047

(b) Percent of class: 12.3%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 5,700,047

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 5,700,047

 

B. Oracle Partners, LP

(a) Amount beneficially owned: 3,912,425

(b) Percent of class: 8.5%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 3,912,425

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 3,912,425

 

C. Oracle Institutional Partners, LP

(a) Amount beneficially owned: 516,588

(b) Percent of class: 1.2%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 516,588

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 516,588

 

 

 

 

D. Oracle Ten Fund, LP

(a) Amount beneficially owned: 1,271,034

(b) Percent of class: 2.8%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 1,271,034

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 1,271,034

 

E. Oracle Associates, LLC

(a) Amount beneficially owned: 5,700,047

(b) Percent of class: 12.3%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 5,700,047

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 5,700,047

 

F. Oracle Investment Management, Inc.

(a) Amount beneficially owned: 5,700,047

(b) Percent of class: 12.3%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 5,700,047

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 5,700,047

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2020

 

 

 

  /s/ Larry N. Feinberg
  Larry N. Feinberg, Individually
   
  ORACLE PARTNERS, LP
  By: ORACLE ASSOCIATES, LLC, its general partner
   
  By: /s/ Larry N. Feinberg
  Larry N. Feinberg, Managing Member
   
  ORACLE TEN FUND, LP
   
  By:  /s/ Larry N. Feinberg
  Larry N. Feinberg, Managing Member
   
  ORACLE INSTITUTIONAL PARTNERS, LP
  By: ORACLE ASSOCIATES, LLC, its general partner
   
  By: /s/ Larry N. Feinberg
  Larry N. Feinberg, Managing Member
   
  ORACLE ASSOCIATES, LLC
   
  By: /s/ Larry N. Feinberg
  Larry N. Feinberg, Managing Member
   
  ORACLE INVESTMENT MANAGEMENT, INC.
   
  By: /s/ Larry N. Feinberg
  Larry N. Feinberg, President